Type 1 diabetes trials in Germany

In Germany 27 Also abroad 537

27 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Long-Term Outcomes of Teplizumab in Routine Clinical Care
Where
Hanover
People
1,000 worldwide
Run by
Sanofi
See details and how to joinNCT07360080
No phaseTaking people
Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)
Where
Augsburg, Frankfurt, Hanover, Munich
People
60 worldwide
Run by
Sanofi
See details and how to joinNCT07457580
Phase 3Taking people
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
Where
Augsburg, Dresden, Hanover, München
Age
1 year to 35 years
People
150 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07222137 · EU 2025-521797-34-00
Phase 3Taking people
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Where
Hanover, Hof, Karlsburg, Ludwigshafen am Rhein, Munich, Oldenburg in Holstein, Sankt Augustin, Ulm
Age
1 year to 35 years
People
300 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07222332 · EU 2025-522170-36-00
No phaseTaking people
RIGHTEST iFree 2 CGM in Pregnant Women With Diabetes Study
Where
Ulm
Age
18 years and over
People
104
Run by
Bionime Corporation
See details and how to joinNCT07889388
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Where
Berlin, Bochum, Bünde, Dresden, Frankfurt am Main, Frankfurt Am Main, Freiburg im Breisgau, Goettingen, Hamburg, Hanover, Homburg, Jerichow, Karlsruhe, Leipzig, Magdeburg, Mainz, München, Munich, Offenbach Am Main, Schwerin, Speyer, Wiesbaden, Zwenkau
Age
18 years and over
People
2,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00
Phase 1Not yet taking people in Germany
A Research Study to Check the Safety of NNC9836-0001 When Given to Healthy Participants and Participants With Type 2 Diabetes
Where
Neuss
Age
25 years to 69 years
People
121
Run by
Novo Nordisk A/S
See details and how to joinNCT07896109 · EU 2026-525819-14-00
Phase 4Taking people
Anti-viral action against Type 1 diabetes autoimmunity GPPAD-05-AVAnT1A
Where
Dresden, Hanover, Munich
Age
Up to 17 years
People
2,365 worldwide
Run by
Klinikum rechts der Isar der TU Muenchen AöR
See details and how to join2023-507348-35-00 · EU 2023-507348-35-00
No phaseTaking people
Changes in Person-reported Outcomes and Behavior Using the Accu-Chek SmartGuide CGM and Predict App
Where
Bad Mergentheim
Age
18 years and over
People
89
Run by
FIDAM RDC
See details and how to joinNCT07814508
Phase 3Taking people
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Where
Augsburg, Bielefeld, Dresden, Frankfurt, Freiburg im Breisgau, Hanover, Leipzig, Munich, Ulm
Age
1 year to 25 years
People
723 worldwide
Run by
Sanofi
See details and how to joinNCT07088068
Phase 2Taking people
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Where
Augsburg, Hanover, Munich
Age
5 years to 40 years
People
159 worldwide
Run by
SAb Biotherapeutics, Inc.
See details and how to joinNCT07187531 · EU 2025-521560-36-00
Phase 1Taking people
A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes
Where
Neuss
Age
18 years to 64 years
People
124
Run by
Eli Lilly and Company
See details and how to joinNCT06945406 · EU 2024-519151-28-00
Phase 3Taking people
A trial to learn how safe elecoglipron is and how well it works in adults living with obesity or excess body weight with or without type 2 diabetes
Where
Bad Oeynhausen, Bochum, Cologne, Dresden, Falkensee, Gera, Hamburg, Köln, Leipzig, Luebeck, Mainz, Mannheim, Muenster, München, Nürnberg, Obertshausen, Oldenburg in Holstein, Stuttgart, Ulm, Wangen im Allgäu, Wuerzburg
Age
18 years and over
People
1,010 worldwide
Run by
AstraZeneca AB
See details and how to join2025-524688-19-00 · EU 2025-524688-19-00
Phase 3Taking people
A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
Where
Dresden
Age
18 years to 65 years
People
57 worldwide
Run by
Vertex Pharmaceuticals Incorporated
See details and how to joinNCT04786262 · EU 2024-513929-23-00
Phase 3Taking people
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Where
Deggingen, Essen, Gelnhausen, Hamburg, Hohenmölsen, Jerichow, Leipzig, Ratingen
Age
45 years and over
People
1,778 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07797335
No phaseTaking people
INNODIA Family & Friends Early-Stage T1D Detection Protocol
Where
Greifswald
Age
1 year to 45 years
People
30,000 worldwide
Run by
INNODIA iVZW
See details and how to joinNCT07118098
Phase 1Taking people
Bioavailability, Biopotency and Food Effect Study of SCD0503 Compared to Subcutaneous Regular Human Insulin
Where
Neuss
Age
18 years to 64 years
People
16
Run by
Sam Chun Dang Pharm. Co. Ltd.
See details and how to joinNCT07634770
Phase 1Taking people
A Research Study Investigating the Effect of NNC0497-0040 in Healthy Participants, Participants With Overweight or Obesity, and Participants With Type 1 Diabetes With Overweight or Obesity
Where
Neuss
Age
18 years to 55 years
People
146
Run by
Novo Nordisk A/S
See details and how to joinNCT07578584
No phaseNot yet taking people in Germany
Evaluation of the Safety and Effectiveness of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in Adults Living With Type 1 Diabetes
Where
Bad Oeynhausen, Hamburg, Rostock
Age
18 years and over
People
230 worldwide
Run by
Medtronic MiniMed, Inc.
See details and how to joinNCT07401901
No phaseTaking people
Disentangling the Effect of Brain Insulin Resistance on Brain Health
Where
Ulm
Age
50 years to 80 years
People
150 worldwide
Run by
Henrik Bo Wiberg Larsson
See details and how to joinNCT07374705
No phaseTaking people
Precision Subclassification of Mental Health in Diabetes: Digital Twins for Precision Mental Health to Track Subgroups
Where
Bad Mergentheim, Würzburg
Age
18 years to 80 years
People
1,809
Run by
Forschungsinstitut der Diabetes Akademie Mergentheim
See details and how to joinNCT07212075
Phase 1Taking people
Clamp Study to Estimate the Relative Potency of GZR33 Versus Insulin Degludec at Steady State
Where
Neuss
Age
18 years to 64 years
People
12
Run by
Gan and Lee Pharmaceuticals, USA
See details and how to joinNCT07242664
Phase 4Taking people
Anti-viral Action Against Type 1 Diabetes Autoimmunity
Where
Dresden, Hanover, Munich
Age
3 months to 4 months
People
2,252 worldwide
Run by
Technical University of Munich
See details and how to joinNCT06452654
No phaseTaking people
Prospective Study on Diabetes Mellitus and Its Complications in Newly Diagnosed Adult Patients
Where
Düsseldorf
Age
18 years to 69 years
People
2,000
Run by
German Diabetes Center
See details and how to joinNCT01055093
No phaseTaking people
Freder1k-Study - Testing Infants for Type 1 Diabetes Risk
Where
Munich
Age
1 day to 6 weeks
People
1,000,000
Run by
Helmholtz Zentrum München
See details and how to joinNCT03316261